ONCURE HOLDINGS INC

CIK:0001375424|SEC Filings

Unconsolidated Joint Ventures (Condensed Results Of Operations Of Memorial) (Details) (Memorial Southside Cancer Center, LLC [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Memorial Southside Cancer Center, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Net revenue	$ 442	$ 790	$ 1,046	$ 1,380
Expenses	415	444	794	717
Net income	$ 27	$ 346	$ 252	$ 663

Guarantors Of Debt (Consolidating Statements Of Cash Flow) (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating activities
Net (loss) income	$ (5,778)	$ (4,001)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Equity interest in net earnings of joint ventures	(154)	(162)
Depreciation and amortization	7,863	9,086
Deferred income tax provision	(2,022)	(2,354)
Other, net	2,489	2,912
Changes in operating assets and liabilities	1,090	(2,609)
Net cash provided by operating activities	3,488	2,872
Investing activities
Purchases of property and equipment	(1,427)	(2,822)
Distribution received from unconsolidated joint ventures	131	196
Investment in unconsolidated joint venture	(900)	0
Net cash used in investing activities	(2,196)	(2,626)
Financing activities
Principal repayments of debt	(240)	(236)
Principal repayments of capital leases	(679)	(878)
Noncontrolling interest in partnership distributions	(26)	0
Payment of debt issuance costs	0	(17)
Net cash used in financing activities	(945)	(1,131)
Net increase (decrease) in cash	347	(885)
Cash, beginning of period	6,988	7,047
Cash, end of period	7,335	6,162
Issuer OnCure Holdings, Inc. [Member]
Operating activities
Net (loss) income	(5,778)	(4,001)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Equity interest in net earnings of joint ventures	0	0
Depreciation and amortization	0	0
Deferred income tax provision	(3,367)	(4,766)
Other, net	0	0
Changes in operating assets and liabilities	9,145	8,767
Net cash provided by operating activities	0	0
Investing activities
Purchases of property and equipment	0	0
Distribution received from unconsolidated joint ventures	0	0
Investment in unconsolidated joint venture	0
Net cash used in investing activities	0	0
Financing activities
Principal repayments of debt	0	0
Principal repayments of capital leases	0	0
Noncontrolling interest in partnership distributions	0
Payment of debt issuance costs		0
Net cash used in financing activities	0	0
Net increase (decrease) in cash	0	0
Cash, beginning of period	0	0
Cash, end of period	0	0
Subsidiary Guarantors [Member]
Operating activities
Net (loss) income	3,855	4,114
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Equity interest in net earnings of joint ventures	(154)	(162)
Depreciation and amortization	7,863	9,086
Deferred income tax provision	1,345	2,412
Other, net	2,489	2,912
Changes in operating assets and liabilities	(11,910)	(15,490)
Net cash provided by operating activities	3,488	2,872
Investing activities
Purchases of property and equipment	(1,427)	(2,822)
Distribution received from unconsolidated joint ventures	131	196
Investment in unconsolidated joint venture	(900)
Net cash used in investing activities	(2,196)	(2,626)
Financing activities
Principal repayments of debt	(240)	(236)
Principal repayments of capital leases	(679)	(878)
Noncontrolling interest in partnership distributions	(26)
Payment of debt issuance costs		(17)
Net cash used in financing activities	(945)	(1,131)
Net increase (decrease) in cash	347	(885)
Cash, beginning of period	6,988	7,047
Cash, end of period	7,335	6,162
Subsidiary Non-Guarantors [Member]
Operating activities
Net (loss) income	0	0
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Equity interest in net earnings of joint ventures	0	0
Depreciation and amortization	0	0
Deferred income tax provision	0	0
Other, net	0	0
Changes in operating assets and liabilities	0	0
Net cash provided by operating activities	0	0
Investing activities
Purchases of property and equipment	0	0
Distribution received from unconsolidated joint ventures	0	0
Investment in unconsolidated joint venture	0
Net cash used in investing activities	0	0
Financing activities
Principal repayments of debt	0	0
Principal repayments of capital leases	0	0
Noncontrolling interest in partnership distributions	0
Payment of debt issuance costs		0
Net cash used in financing activities	0	0
Net increase (decrease) in cash	0	0
Cash, beginning of period	0	0
Cash, end of period	0	0
Eliminations / Adjustments [Member]
Operating activities
Net (loss) income	(3,855)	(4,114)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Equity interest in net earnings of joint ventures	0	0
Depreciation and amortization	0	0
Deferred income tax provision	0	0
Other, net	0	0
Changes in operating assets and liabilities	3,855	4,114
Net cash provided by operating activities	0	0
Investing activities
Purchases of property and equipment	0	0
Distribution received from unconsolidated joint ventures	0	0
Investment in unconsolidated joint venture	0
Net cash used in investing activities	0	0
Financing activities
Principal repayments of debt	0	0
Principal repayments of capital leases	0	0
Noncontrolling interest in partnership distributions	0
Payment of debt issuance costs		0
Net cash used in financing activities	0	0
Net increase (decrease) in cash	0	0
Cash, beginning of period	0	0
Cash, end of period	$ 0	$ 0

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Current assets:
Cash	$ 7,335	$ 6,988
Accounts receivable, less allowances of $1,827 and $1,788, respectively	16,894	18,812
Deferred income taxes	1,391	1,391
Prepaid expenses	2,424	2,477
Other current assets	841	991
Total current assets	28,885	30,659
Property and equipment, net	30,811	31,117
Goodwill	174,353	174,353
Management service agreements, net	42,223	45,295
Other assets, net	12,519	12,055
Total assets	288,791	293,479
Current liabilities:
Accounts payable	1,402	1,709
Accrued expenses	10,103	6,436
Accrued interest	3,084	3,084
Current portion of note payable	52	292
Current portion of obligations under capital leases	1,306	1,341
Other current liabilities	619	446
Total current liabilities	16,566	13,308
Long-term debt, net of unamortized discount of $2,840 and $3,049, respectively, less current portion	207,160	206,951
Capital leases, less current portion	1,502	2,146
Other long-term liabilities	2,454	2,403
Deferred income tax liabilities	10,586	12,608
Total liabilities	238,268	237,416
OnCure Holdings, Inc. stockholders' equity:
Preferred stock, $0.001 par value, 1,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $0.001 par value, 50,000,000 shares authorized, 26,317,675 shares issued and outstanding	26	26
Additional paid-in capital	96,563	96,299
Accumulated deficit	(48,545)	(42,668)
Total OnCure Holdings, Inc. stockholders' equity	48,044	53,657
Noncontrolling interest	2,479	2,406
Total stockholders' equity	50,523	56,063
Total liabilities and stockholders' equity	$ 288,791	$ 293,479